Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Neal

Showing results (471-480 of 521) with videos related to

Pageof 53
Sort By:
Journal of Clinical Medicine|July 24, 2021
Preventing Thrombohemorrhagic Complications of Heparinized COVID-19 Patients Using Adjunctive Thromboelastography: A Retrospective StudyConnor M Bunch, Anthony V Thomas, John E Stillson, et al.
JAMA Surgery|October 5, 2020
Tranexamic Acid During Prehospital Transport in Patients at Risk for Hemorrhage After Injury: A Double-blind, Placebo-Controlled, Randomized Clinical TrialFrancis X Guyette, Joshua B Brown, Mazen S Zenati, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 21, 2024
Prospective Evaluation of Lung Cancer Screening Eligibility Criteria and Lung Cancer Detection in the Yorkshire Lung Screening TrialRhian Gabe, Philip A J Crosbie, Daniel Vulkan, et al.
Research Square|January 14, 2021
Lipidomic Signatures Align with Inflammatory Patterns and Outcomes in Critical IllnessJunru Wu, Anthony Cyr, Danielle S Gruen, et al.
Seminars in Thrombosis and Hemostasis|September 29, 2022
Relative Hypercoagulopathy of the SARS-CoV-2 Beta and Delta Variants when Compared to the Less Severe Omicron Variants Is Related to TEG Parameters, the Extent of Fibrin Amyloid Microclots, and the Severity of Clinical IllnessLize M Grobbelaar, Arneaux Kruger, Chantelle Venter, et al.
Science Advances|September 13, 2021
Platelets amplify endotheliopathy in COVID-19Tessa J Barrett, MacIntosh Cornwell, Khrystyna Myndzar, et al.
Journal of the American Heart Association|May 6, 2026
Soluble Thrombomodulin Links Viremia and Mortality During COVID-19: Results From the ACTIV-4a TrialBenjamin E Zuchelkowski, Kyle W Inman, S Mehdi Nouraie, et al.
JAMA|March 21, 2023
Heterogeneous Treatment Effects of Therapeutic-Dose Heparin in Patients Hospitalized for COVID-19Ewan C Goligher, Patrick R Lawler, Thomas P Jensen, et al.
Cell Reports. Medicine|March 19, 2025
High-dimensional analysis of injured patients reveals distinct circulating proteomic profiles in plasma vs. whole blood resuscitationHamed Moheimani, Xuejing Sun, Mehves Ozel, et al.
The Journal of Trauma and Acute Care Surgery|April 30, 2024
Four-factor prothrombin complex concentrate is not inferior to andexanet alfa for the reversal or oral factor Xa inhibitors: An Eastern Association for the Surgery of Trauma multicenter studyJordan M Estroff, Joseph Devlin, Lara Hoteit, et al.
Pageof 53

Showing results (471-480 of 521) with videos related to

Sort By:
Pageof 53
Journal of Clinical Medicine|July 24, 2021
Preventing Thrombohemorrhagic Complications of Heparinized COVID-19 Patients Using Adjunctive Thromboelastography: A Retrospective StudyConnor M Bunch, Anthony V Thomas, John E Stillson, et al.
JAMA Surgery|October 5, 2020
Tranexamic Acid During Prehospital Transport in Patients at Risk for Hemorrhage After Injury: A Double-blind, Placebo-Controlled, Randomized Clinical TrialFrancis X Guyette, Joshua B Brown, Mazen S Zenati, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 21, 2024
Prospective Evaluation of Lung Cancer Screening Eligibility Criteria and Lung Cancer Detection in the Yorkshire Lung Screening TrialRhian Gabe, Philip A J Crosbie, Daniel Vulkan, et al.
Research Square|January 14, 2021
Lipidomic Signatures Align with Inflammatory Patterns and Outcomes in Critical IllnessJunru Wu, Anthony Cyr, Danielle S Gruen, et al.
Seminars in Thrombosis and Hemostasis|September 29, 2022
Relative Hypercoagulopathy of the SARS-CoV-2 Beta and Delta Variants when Compared to the Less Severe Omicron Variants Is Related to TEG Parameters, the Extent of Fibrin Amyloid Microclots, and the Severity of Clinical IllnessLize M Grobbelaar, Arneaux Kruger, Chantelle Venter, et al.
Science Advances|September 13, 2021
Platelets amplify endotheliopathy in COVID-19Tessa J Barrett, MacIntosh Cornwell, Khrystyna Myndzar, et al.
Journal of the American Heart Association|May 6, 2026
Soluble Thrombomodulin Links Viremia and Mortality During COVID-19: Results From the ACTIV-4a TrialBenjamin E Zuchelkowski, Kyle W Inman, S Mehdi Nouraie, et al.
JAMA|March 21, 2023
Heterogeneous Treatment Effects of Therapeutic-Dose Heparin in Patients Hospitalized for COVID-19Ewan C Goligher, Patrick R Lawler, Thomas P Jensen, et al.
Cell Reports. Medicine|March 19, 2025
High-dimensional analysis of injured patients reveals distinct circulating proteomic profiles in plasma vs. whole blood resuscitationHamed Moheimani, Xuejing Sun, Mehves Ozel, et al.
The Journal of Trauma and Acute Care Surgery|April 30, 2024
Four-factor prothrombin complex concentrate is not inferior to andexanet alfa for the reversal or oral factor Xa inhibitors: An Eastern Association for the Surgery of Trauma multicenter studyJordan M Estroff, Joseph Devlin, Lara Hoteit, et al.
Pageof 53